MeSH term
Frequency | Condition_Probility | Adenosinetriphosphatase/genetics/metabolism | 2 | 8.0 |
Animals | 27 | 0.0 |
*DNA Repair Enzymes | 12 | 12.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Exons | 9 | 0.0 |
Female | 64 | 0.0 |
Male | 56 | 0.0 |
Mice | 16 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Microsatellite Repeats | 23 | 1.0 |
Molecular Sequence Data | 27 | 0.0 |
Neoplasm Proteins/genetics/metabolism | 3 | 2.0 |
Research Support, Non-U.S. Gov't | 85 | 0.0 |
*Base Pair Mismatch | 20 | 21.0 |
*DNA Repair | 29 | 4.0 |
Alleles | 7 | 0.0 |
Colorectal Neoplasms/*genetics | 7 | 3.0 |
*DNA-Binding Proteins | 25 | 1.0 |
Dinucleotide Repeats/genetics | 2 | 4.0 |
Endometrial Neoplasms/*genetics | 5 | 10.0 |
Germ-Line Mutation | 16 | 4.0 |
Humans | 130 | 0.0 |
*Microsatellite Repeats | 10 | 4.0 |
Neoplasm Proteins/genetics | 16 | 3.0 |
Phosphoric Monoester Hydrolases/genetics | 2 | 2.0 |
Proto-Oncogene Proteins/genetics | 16 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 45 | 0.0 |
Trinucleotide Repeat Expansion | 2 | 5.0 |
DNA Damage | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Adult | 38 | 0.0 |
Aged | 31 | 0.0 |
Aged, 80 and over | 11 | 0.0 |
Base Pair Mismatch | 22 | 13.0 |
DNA Repair | 21 | 3.0 |
DNA-Binding Proteins/analysis | 3 | 3.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Middle Aged | 51 | 0.0 |
Neoplasm Proteins/analysis | 3 | 0.0 |
Proto-Oncogene Proteins/analysis | 2 | 1.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics | 20 | 21.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Mutation, Missense | 2 | 0.0 |
Adolescent | 2 | 0.0 |
DNA, Neoplasm/*genetics | 3 | 1.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Immunohistochemistry | 23 | 0.0 |
Microsatellite Repeats/*genetics | 13 | 4.0 |
Neoplasm Proteins/metabolism | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Base Pair Mismatch/*genetics | 12 | 21.0 |
Neoplasms, Multiple Primary/*genetics | 4 | 10.0 |
Colonic Neoplasms/*genetics/pathology | 2 | 4.0 |
DNA Mutational Analysis | 32 | 0.0 |
DNA, Neoplasm/chemistry/genetics | 2 | 1.0 |
Genetic Heterogeneity | 2 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Mutation | 16 | 0.0 |
Ploidies | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid/*genetics | 2 | 1.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 3 | 0.0 |
Trinucleotide Repeat Expansion/genetics | 3 | 7.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Hela Cells | 9 | 0.0 |
Phosphorylation | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 3 | 0.0 |
Neoplasm Proteins/biosynthesis/*genetics | 4 | 4.0 |
Proto-Oncogene Proteins/biosynthesis/*genetics | 2 | 3.0 |
DNA, Neoplasm/genetics | 4 | 0.0 |
Germ-Line Mutation/*genetics | 10 | 6.0 |
Neoplasm Proteins/*genetics | 15 | 1.0 |
Pedigree | 21 | 0.0 |
Polymerase Chain Reaction | 12 | 0.0 |
Proto-Oncogene Proteins/*genetics | 15 | 1.0 |
DNA-Binding Proteins/*genetics | 22 | 1.0 |
*Gene Rearrangement | 2 | 0.0 |
Point Mutation | 4 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 5 | 2.0 |
*Multidrug Resistance-Associated Proteins | 16 | 29.0 |
Binding Sites | 3 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics/*metabolism | 3 | 100.0 |
Polymorphism, Single Nucleotide/*genetics | 2 | 0.0 |
Protein Binding | 7 | 0.0 |
Age of Onset | 8 | 0.0 |
Colorectal Neoplasms/epidemiology/*genetics | 2 | 15.0 |
Endometrial Neoplasms/epidemiology/*genetics | 2 | 50.0 |
*Heterozygote | 4 | 1.0 |
Microsatellite Repeats/genetics | 13 | 3.0 |
Phenotype | 16 | 0.0 |
Blotting, Western | 4 | 0.0 |
Colorectal Neoplasms/*genetics/pathology | 5 | 5.0 |
*Genetic Predisposition to Disease | 7 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics/*pathology | 2 | 66.0 |
Frameshift Mutation/genetics | 2 | 2.0 |
Mutation/*genetics | 6 | 0.0 |
Cell Line | 2 | 0.0 |
Drug Resistance | 2 | 0.0 |
Genes, p53 | 2 | 0.0 |
Genetic Predisposition to Disease | 5 | 0.0 |
*Mutation | 14 | 0.0 |
Age Factors | 3 | 0.0 |
Base Pair Mismatch/genetics | 6 | 13.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/epidemiology/*genetics | 3 | 37.0 |
Comparative Study | 16 | 0.0 |
DNA Repair/genetics | 10 | 5.0 |
Heterozygote | 2 | 0.0 |
Netherlands/epidemiology | 2 | 1.0 |
Risk Factors | 3 | 0.0 |
Fungal Proteins/*genetics | 4 | 3.0 |
Gene Deletion | 6 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 14 | 1.0 |
Sensitivity and Specificity | 8 | 0.0 |
Base Sequence | 22 | 0.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Genetic Markers | 2 | 0.0 |
Disease Progression | 4 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Cells, Cultured | 4 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Survival Rate | 2 | 0.0 |
Genetic Screening/methods | 2 | 1.0 |
Diagnosis, Differential | 3 | 0.0 |
Genetic Predisposition to Disease/genetics | 3 | 0.0 |
Genotype | 3 | 0.0 |
Netherlands | 3 | 1.0 |
Penetrance | 2 | 1.0 |
Colonic Neoplasms/genetics | 2 | 3.0 |
DNA Repair/*genetics | 14 | 4.0 |
Endometrial Neoplasms/genetics | 4 | 25.0 |
English Abstract | 4 | 0.0 |
Ovarian Neoplasms/genetics | 2 | 1.0 |
Rectal Neoplasms/genetics | 2 | 22.0 |
Stomach Neoplasms/genetics | 3 | 12.0 |
Genetic Screening | 4 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Dimerization | 4 | 0.0 |
Neoplasm Proteins/*biosynthesis | 2 | 2.0 |
Prognosis | 2 | 0.0 |
Proto-Oncogene Proteins/*biosynthesis | 4 | 2.0 |
Neoplasm Proteins/biosynthesis/genetics | 2 | 1.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Tumor Cells, Cultured/radiation effects | 2 | 5.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics | 4 | 9.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
*Adenosinetriphosphatase | 8 | 10.0 |
Hamsters | 4 | 0.0 |
Methylnitronitrosoguanidine/pharmacology | 2 | 8.0 |
Proteins/genetics | 3 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Family Health | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Risk | 3 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Chromosomes, Human, Pair 2/genetics | 2 | 1.0 |
Frameshift Mutation | 7 | 1.0 |
Hybrid Cells | 2 | 0.0 |
Mutagenesis, Insertional | 4 | 1.0 |
Sequence Deletion | 8 | 0.0 |
Genetic Screening/*methods | 2 | 1.0 |
Mutation/genetics | 4 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Amino Acid Sequence | 11 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Fungal Proteins/metabolism | 3 | 1.0 |
Proliferating Cell Nuclear Antigen/*metabolism | 2 | 1.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
DNA Mutational Analysis/methods | 3 | 1.0 |
Frameshift Mutation/*genetics | 3 | 5.0 |
*Arabidopsis Proteins | 2 | 2.0 |
*Escherichia coli Proteins | 3 | 1.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
DNA Primers | 2 | 0.0 |
DNA-Binding Proteins/genetics | 9 | 1.0 |
*Genes, Fungal | 2 | 1.0 |
Saccharomyces cerevisiae/*genetics | 3 | 1.0 |
B-Lymphocytes/cytology/immunology | 2 | 6.0 |
Cytidine Deaminase/metabolism | 2 | 18.0 |
DNA-Directed DNA Polymerase/metabolism | 2 | 6.0 |
*Immunoglobulin Class Switching | 2 | 15.0 |
Mice, Knockout | 3 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
*Recombination, Genetic | 3 | 0.0 |
*Somatic Hypermutation, Immunoglobulin | 2 | 20.0 |
Colorectal Neoplasms/*genetics/metabolism/pathology | 2 | 10.0 |
DNA-Binding Proteins/*genetics/metabolism | 4 | 0.0 |
Exons/genetics | 4 | 0.0 |
Germ-Line Mutation/genetics | 3 | 4.0 |
Transcription, Genetic | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/diagnosis/*genetics | 2 | 16.0 |
Genome, Human | 2 | 0.0 |
*Alleles | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics/pathology | 4 | 57.0 |
*Proto-Oncogene Proteins c-bcl-2 | 3 | 0.0 |
Receptors, Transforming Growth Factor beta/genetics | 2 | 3.0 |
Chromosomal Instability/genetics | 2 | 66.0 |
Family | 3 | 0.0 |
Bacterial Proteins/*genetics | 2 | 3.0 |
Blotting, Northern | 3 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis | 5 | 4.0 |
*Germ-Line Mutation | 9 | 2.0 |
Neoplasm Proteins/analysis/genetics | 2 | 8.0 |
Proto-Oncogene Proteins/analysis/genetics | 2 | 7.0 |
*Genetic Screening | 4 | 2.0 |
Proteins/metabolism | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Loss of Heterozygosity | 3 | 0.0 |
DNA, Neoplasm/analysis | 6 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
DNA Replication/genetics | 2 | 3.0 |
*DNA Methylation | 4 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
*Nucleic Acid Heteroduplexes | 3 | 20.0 |
*Chromosomes, Human, Pair 2 | 2 | 0.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Fungal Proteins/*metabolism | 2 | 2.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
DNA, Neoplasm | 2 | 1.0 |
Proto-Oncogene Proteins/biosynthesis/genetics | 2 | 2.0 |
Cohort Studies | 5 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Transfection | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis | 2 | 100.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 2 | 1.0 |
DNA Methylation | 2 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Cost-Benefit Analysis | 2 | 1.0 |
RNA, Messenger/analysis | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*epidemiology/*genetics | 2 | 66.0 |
Heterozygote Detection | 2 | 0.0 |
